Literature DB >> 21436254

B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR.

Stephanie C Casey1, Edward L Nelson, Gina M Turco, Matthew R Janes, David A Fruman, Bruce Blumberg.   

Abstract

The steroid and xenobiotic receptor (SXR) is a broad-specificity nuclear hormone receptor that is highly expressed in the liver and intestine, where its primary function is to regulate drug and xenobiotic metabolism. SXR is expressed at lower levels in other tissues, where little is known about its physiological functions. We previously linked SXR with immunity and inflammation by showing that SXR antagonizes the activity of nuclear factor (NF)-κB in vitro and in vivo. SXR(-/-) mice demonstrate aberrantly high NF-κB activity and overexpression of NF-κB target genes. Here we show that SXR(-/-) mice develop B cell lymphoma in an age-dependent manner. SXR(-/-) mice develop multiple hyperplastic lymphoid foci composed of B-1a cells in the intestine, spleen, lymph nodes, peritoneal cavity, and blood. In all circumstances, these lymphocytes possess cell surface and molecular characteristics of either chronic lymphocytic leukemia or non-Hodgkin's lymphoma originating from B-1 lymphocytes. These results demonstrate a novel and unsuspected role for SXR signaling in the B-1 cell compartment, establish SXR as a tumor suppressor in B-1 cells, and may provide a link between metabolism of xenobiotic compounds and lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436254      PMCID: PMC3100607          DOI: 10.1210/me.2010-0486

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  55 in total

1.  Persistent organochlorine chemicals in plasma and risk of non-Hodgkin's lymphoma.

Authors:  Anneclaire J De Roos; Patricia Hartge; Jay H Lubin; Joanne S Colt; Scott Davis; James R Cerhan; Richard K Severson; Wendy Cozen; Donald G Patterson; Larry L Needham; Nathaniel Rothman
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 2.  CD5 B cells, a fetal B cell lineage.

Authors:  R R Hardy; K Hayakawa
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

3.  Expression of the T-cell-specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells.

Authors:  M B Majolini; M M D'Elios; P Galieni; M Boncristiano; F Lauria; G Del Prete; J L Telford; C T Baldari
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

4.  NF-kappaB transcription factors are involved in normal erythropoiesis.

Authors:  M Y Zhang; S C Sun; L Bell; B A Miller
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

5.  Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.

Authors:  Nadine Albermann; Friedrich Hubertus Schmitz-Winnenthal; Kaspar Z'graggen; Christine Volk; Michael Marcus Hoffmann; Walter Emil Haefeli; Johanna Weiss
Journal:  Biochem Pharmacol       Date:  2005-09-15       Impact factor: 5.858

6.  A Nuclear Receptor Atlas: macrophage activation.

Authors:  Grant D Barish; Michael Downes; William A Alaynick; Ruth T Yu; Corinne B Ocampo; Angie L Bookout; David J Mangelsdorf; Ronald M Evans
Journal:  Mol Endocrinol       Date:  2005-07-28

7.  SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.

Authors:  B Cuevas; Y Lu; S Watt; R Kumar; J Zhang; K A Siminovitch; G B Mills
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

8.  Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.

Authors:  C Cameron Yin; Pei Lin; Dennis A Carney; Beverly C Handy; George Z Rassidakis; Joan H Admirand; Michael J Keating; L Jeffrey Medeiros
Journal:  Am J Clin Pathol       Date:  2005-04       Impact factor: 2.493

9.  Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.

Authors:  Anja Hoffmann; Sheena Kerr; Julia Jellusova; Jiquan Zhang; Florian Weisel; Ute Wellmann; Thomas H Winkler; Burkhard Kneitz; Paul R Crocker; Lars Nitschke
Journal:  Nat Immunol       Date:  2007-06-17       Impact factor: 25.606

10.  Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

Authors:  R Schroers; F Griesinger; L Trümper; D Haase; B Kulle; L Klein-Hitpass; L Sellmann; U Dührsen; J Dürig
Journal:  Leukemia       Date:  2005-05       Impact factor: 11.528

View more
  11 in total

1.  SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.

Authors:  Giorgia Simonetti; Maria Teresa Sabrina Bertilaccio; Tania Veliz Rodriguez; Benedetta Apollonio; Antonis Dagklis; Martina Rocchi; Anna Innocenzi; Stefano Casola; Thomas H Winkler; Lars Nitschke; Maurilio Ponzoni; Federico Caligaris-Cappio; Paolo Ghia
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

2.  Alzheimer's disease risk factor lymphocyte-specific protein tyrosine kinase regulates long-term synaptic strengthening, spatial learning and memory.

Authors:  Eun-Jung Kim; Francisco J Monje; Lin Li; Harald Höger; Daniela D Pollak; Gert Lubec
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 3.  Novel functions of PXR in cardiometabolic disease.

Authors:  Changcheng Zhou
Journal:  Biochim Biophys Acta       Date:  2016-02-26

Review 4.  Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.

Authors:  Guo-Yun Chen; Nicholas K Brown; Pan Zheng; Yang Liu
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

5.  The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver.

Authors:  Stephanie C Casey; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2012-04-11

Review 6.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

7.  Pregnane X Receptor and Cancer: Context-Specificity is Key.

Authors:  Satyanarayana R Pondugula; Petr Pavek; Sridhar Mani
Journal:  Nucl Receptor Res       Date:  2016-06-12

8.  Myeloid-specific deficiency of pregnane X receptor decreases atherosclerosis in LDL receptor-deficient mice.

Authors:  Yipeng Sui; Zhaojie Meng; Se-Hyung Park; Weiwei Lu; Christopher Livelo; Qi Chen; Tong Zhou; Changcheng Zhou
Journal:  J Lipid Res       Date:  2020-03-13       Impact factor: 5.922

Review 9.  Immunological cells and functions in Gaucher disease.

Authors:  Manoj Kumar Pandey; Gregory A Grabowski
Journal:  Crit Rev Oncog       Date:  2013

Review 10.  Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development.

Authors:  Silvia Marchese; Andrea Polo; Andrea Ariano; Salvatore Velotto; Susan Costantini; Lorella Severino
Journal:  Toxins (Basel)       Date:  2018-05-24       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.